//
Ilias Kounis - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A
Soon Kyu Lee - American Association for the Study of Liver Diseases (The Liver Meeting) (AASLD) , 2019
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Venous thrombosis
N/A
Panagiotis Mourelatos - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Venous thrombosis
N/A
Ridvan Fevzi Degirmenciler - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Venous thrombosis
Levothyroxine
Mariana Gomes Porras - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Venous thrombosis
Hydroxychloroquine
Mohamad Mustafa - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Tetracosactide
Pramod Manjunath - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Endocrine/metabolic Diseases (ME)
Venous thrombosis
Aspirin
Francisca Puga - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Substance Abuse
Venous thrombosis
Hydroxyzine
Diogo Ramalho - European Congress of Endocrinology (ECE) , 2020
Therapeutic Area
Disease
Drug/Treatment
Endocrine/metabolic Diseases (ME)
Venous thrombosis
Amoclan suspension
O. Benitez Hidalgo - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Hemostatic Solution
F. Keklik Karadag - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Cyclophosphamide
J. Journeycake - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
rurioctocog alfa
S. Martin-Tellez - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
FVIII
K. McCloskey - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Venous thrombosis
Prednisolone
S. Campanio - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A
P. Velarde Lopezdeayala - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A
E. Yakovleva - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
Fibrinogen (IV)
SAYYID RONRON DATUKON - Asian Pacific Society of Respirology (APSR) , 2018
Therapeutic Area
Disease
Drug/Treatment
Genetic Disorder
Venous thrombosis
N/A
EUN SEOK KANG - Asian Pacific Society of Respirology (APSR) , 2018
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A
JIEPING LEI - Asian Pacific Society of Respirology (APSR) , 2018
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Venous thrombosis
N/A